In good line with the prediction of BLCA subtypes by TCGA, the high ACSM6 group in the Xiangya cohort better turned to be the luminal subtype, while the low ACSM6 group better turned to be the basal subtype (Figure 6A). The gene discussed is ACSM6; the disease is bladder transitional cell carcinoma.